<DOC>
	<DOCNO>NCT01941680</DOCNO>
	<brief_summary>Patients recruit diagnosis relapse ATLL-HR French Caribbean islands Guyana . They receive Zidovudine Pegylated Interferon ( ZPI ) . For patient young 65 year old , allogeneic donor search . Patients include relapse lymphoma clinico-biological subtype also receive chemotherapy ( CT ) . Responses assess ZPI+/-CT eligible patient ( depend age , comorbidities response criterion ) receive allogeneic transplant . Patient follow-up plan 3 year old</brief_summary>
	<brief_title>High Risk Adult T-cell Leukemia/Lymphoma ( ATLL-HR ) Allogeneic Transplant</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Leukemia-Lymphoma , Adult T-Cell</mesh_term>
	<mesh_term>Zidovudine</mesh_term>
	<criteria>Patient &gt; 18 year old â‰¤ 75 year old , ATLLHR sign informed consent . Pregnant nursing woman eligible ; neither woman childbearing potential unless use effective contraception determine patient 's physician .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>